2022 BRN Discussion, page-6387

OK then...


What about this extract in the jwpm marketing blog.

https://jwpm.com.au/industrial-marketing-blog/brn-brainchip-neuromorphic


Extract

[March 2021 update]

Semico published an article in their March, 2021 IPI Newsletter detailing a press release between NaNose (Nano Artificial Nose) Medical and BrainChip announcing a new system for electronic breath diagnosis of COVID-19. This system used an artificially intelligent nano-array based on molecularly modified gold nanoparticles and a random network of single-walled carbon nanotubes paired with the Akida neuromorphic AI processor from BrainChip.

Since then, NaNose has broadened the spectrum of diseases that can be detected and is working toward commercial release...


__________________________________________

I looks like this same system could also be being used in Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sensing Approach where the identified VOCs will be compared to the compounds in human breath, employing gas chromatography coupled to mass spectrometry as well as a gold nanoparticle micro-array reaction pattern, which I found by looking back through JLM Innovations partners.

https://cordis.europa.eu/project/id/824986

https://www.jlm-innovation.de/about/partners

It also says on the JLM website that Many other sensing technologies are available and may be integrated with our products. Please contact JLM Innovation with your specific requirements.